Evaluation of newer treatment interventions for psychotic depression.

B. L. O'Neal, C. L. Smith, M. Trivedi

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Psychotic depression is characterized by greater severity, higher rate of recurrence, greater incapacitation, more frequent hospitalization, and longer episodes than nonpsychotic depression. The use of combined tricyclic antidepressants (TCAs) and neuroleptic therapy, as well as electroconvulsive therapy, has proven effectiveness in the treatment of psychotic depression. Although it is limited, evidence for efficacy of selective serontonin reuptake inhibitors both alone and in combination with antipsychotics in psychotic depression suggests that these strategies may provide a desirable alternative to the traditional TCA- neuroleptic therapy. These treatments, in addition to the continual introduction of new psychotropic agents suggest that the prospect of future research in this area is promising.

Original languageEnglish (US)
Pages (from-to)305-309
Number of pages5
JournalCurrent Psychiatry Reports
Volume2
Issue number4
StatePublished - Aug 2000

Fingerprint

Depression
Antipsychotic Agents
Tricyclic Antidepressive Agents
Electroconvulsive Therapy
Therapeutics
Hospitalization
Recurrence

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evaluation of newer treatment interventions for psychotic depression. / O'Neal, B. L.; Smith, C. L.; Trivedi, M.

In: Current Psychiatry Reports, Vol. 2, No. 4, 08.2000, p. 305-309.

Research output: Contribution to journalArticle

@article{1e0f7dad67cc4cab9dc147f6120cfd87,
title = "Evaluation of newer treatment interventions for psychotic depression.",
abstract = "Psychotic depression is characterized by greater severity, higher rate of recurrence, greater incapacitation, more frequent hospitalization, and longer episodes than nonpsychotic depression. The use of combined tricyclic antidepressants (TCAs) and neuroleptic therapy, as well as electroconvulsive therapy, has proven effectiveness in the treatment of psychotic depression. Although it is limited, evidence for efficacy of selective serontonin reuptake inhibitors both alone and in combination with antipsychotics in psychotic depression suggests that these strategies may provide a desirable alternative to the traditional TCA- neuroleptic therapy. These treatments, in addition to the continual introduction of new psychotropic agents suggest that the prospect of future research in this area is promising.",
author = "O'Neal, {B. L.} and Smith, {C. L.} and M. Trivedi",
year = "2000",
month = "8",
language = "English (US)",
volume = "2",
pages = "305--309",
journal = "Current Psychiatry Reports",
issn = "1523-3812",
publisher = "Current Science, Inc.",
number = "4",

}

TY - JOUR

T1 - Evaluation of newer treatment interventions for psychotic depression.

AU - O'Neal, B. L.

AU - Smith, C. L.

AU - Trivedi, M.

PY - 2000/8

Y1 - 2000/8

N2 - Psychotic depression is characterized by greater severity, higher rate of recurrence, greater incapacitation, more frequent hospitalization, and longer episodes than nonpsychotic depression. The use of combined tricyclic antidepressants (TCAs) and neuroleptic therapy, as well as electroconvulsive therapy, has proven effectiveness in the treatment of psychotic depression. Although it is limited, evidence for efficacy of selective serontonin reuptake inhibitors both alone and in combination with antipsychotics in psychotic depression suggests that these strategies may provide a desirable alternative to the traditional TCA- neuroleptic therapy. These treatments, in addition to the continual introduction of new psychotropic agents suggest that the prospect of future research in this area is promising.

AB - Psychotic depression is characterized by greater severity, higher rate of recurrence, greater incapacitation, more frequent hospitalization, and longer episodes than nonpsychotic depression. The use of combined tricyclic antidepressants (TCAs) and neuroleptic therapy, as well as electroconvulsive therapy, has proven effectiveness in the treatment of psychotic depression. Although it is limited, evidence for efficacy of selective serontonin reuptake inhibitors both alone and in combination with antipsychotics in psychotic depression suggests that these strategies may provide a desirable alternative to the traditional TCA- neuroleptic therapy. These treatments, in addition to the continual introduction of new psychotropic agents suggest that the prospect of future research in this area is promising.

UR - http://www.scopus.com/inward/record.url?scp=3142621478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3142621478&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 305

EP - 309

JO - Current Psychiatry Reports

JF - Current Psychiatry Reports

SN - 1523-3812

IS - 4

ER -